258 related articles for article (PubMed ID: 26860286)
21. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.
Salt AN; Hartsock J; Plontke S; LeBel C; Piu F
Audiol Neurootol; 2011; 16(5):323-35. PubMed ID: 21178339
[TBL] [Abstract][Full Text] [Related]
22. Trans-Oval-Window Implants, A New Approach for Drug Delivery to the Inner Ear: Extended Dexamethasone Release From Silicone-based Implants.
Sircoglou J; Gehrke M; Tardivel M; Siepmann F; Siepmann J; Vincent C
Otol Neurotol; 2015 Sep; 36(9):1572-9. PubMed ID: 26375981
[TBL] [Abstract][Full Text] [Related]
23. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.
Hahn H; Kammerer B; DiMauro A; Salt AN; Plontke SK
Hear Res; 2006 Feb; 212(1-2):236-44. PubMed ID: 16442251
[TBL] [Abstract][Full Text] [Related]
24. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
25. [In vivo distribution and pharmacokinetics of dexamethasone sodium phosphate thermosensitive in situ gel following intratympanic injection].
Chen G; Hou SX; Liu J; Luan JG; Zhang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):456-9. PubMed ID: 16761433
[TBL] [Abstract][Full Text] [Related]
26. Buffered papaverine facilitates passage of intratympanic dexamethasone to the inner ear.
Naci Ozluoglu L; Yilmaz I; Akkuzu B; Haberal A
Acta Otolaryngol; 2006 Dec; 126(12):1260-5. PubMed ID: 17101586
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid-octadecylamine conjugate.
Sun J; Song Y; Lu M; Lin X; Liu Y; Zhou S; Su Y; Deng Y
Eur J Pharm Sci; 2016 Oct; 93():177-83. PubMed ID: 27539143
[TBL] [Abstract][Full Text] [Related]
28. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders.
Piu F; Wang X; Fernandez R; Dellamary L; Harrop A; Ye Q; Sweet J; Tapp R; Dolan DF; Altschuler RA; Lichter J; LeBel C
Otol Neurotol; 2011 Jan; 32(1):171-9. PubMed ID: 21099726
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone pharmacokinetics in Guinea pig inner ear perilymph.
Liu HJ; Dong MM; Chi FL
ORL J Otorhinolaryngol Relat Spec; 2006; 68(2):93-8. PubMed ID: 16446554
[TBL] [Abstract][Full Text] [Related]
30. Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery.
Liao AH; Shih CP; Li MW; Lin YC; Chuang HC; Wang CH
Drug Deliv; 2021 Dec; 28(1):1256-1271. PubMed ID: 34142922
[TBL] [Abstract][Full Text] [Related]
31. Marker retention in the cochlea following injections through the round window membrane.
Salt AN; Sirjani DB; Hartsock JJ; Gill RM; Plontke SK
Hear Res; 2007 Oct; 232(1-2):78-86. PubMed ID: 17662546
[TBL] [Abstract][Full Text] [Related]
32. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evaluation of a hydrogel reservoir as a continuous drug delivery system for inner ear treatment.
Hütten M; Dhanasingh A; Hessler R; Stöver T; Esser KH; Möller M; Lenarz T; Jolly C; Groll J; Scheper V
PLoS One; 2014; 9(8):e104564. PubMed ID: 25105670
[TBL] [Abstract][Full Text] [Related]
34. Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications.
Sahle FF; Gerecke C; Kleuser B; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):21-31. PubMed ID: 27845215
[TBL] [Abstract][Full Text] [Related]
35. Transtympanic injection of a liposomal gel loaded with N-acetyl-L-cysteine: A relevant strategy to prevent damage induced by cochlear implantation in guinea pigs?
Jaudoin C; Carré F; Gehrke M; Sogaldi A; Steinmetz V; Hue N; Cailleau C; Tourrel G; Nguyen Y; Ferrary E; Agnely F; Bochot A
Int J Pharm; 2021 Jul; 604():120757. PubMed ID: 34058306
[TBL] [Abstract][Full Text] [Related]
36. Novel biodegradable Round Window Disks for inner ear delivery of dexamethasone.
Lehner E; Liebau A; Syrowatka F; Knolle W; Plontke SK; Mäder K
Int J Pharm; 2021 Feb; 594():120180. PubMed ID: 33338566
[TBL] [Abstract][Full Text] [Related]
37. Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
Zhang W; Wang G; See E; Shaw JP; Baguley BC; Liu J; Amirapu S; Wu Z
J Control Release; 2015 Apr; 203():161-9. PubMed ID: 25701612
[TBL] [Abstract][Full Text] [Related]
38. A comparison of cochlear distribution and glucocorticoid receptor activation in local and systemic dexamethasone drug delivery regimes.
Creber NJ; Eastwood HT; Hampson AJ; Tan J; O'Leary SJ
Hear Res; 2018 Oct; 368():75-85. PubMed ID: 29622283
[TBL] [Abstract][Full Text] [Related]
39. Junctional Modulation of Round Window Membrane Enhances Dexamethasone Uptake into the Inner Ear and Recovery after NIHL.
Jeong SH; Kim Y; Lyu AR; Shin SA; Kim TH; Huh YH; Je AR; Gajibhiye A; Yu Y; Jin Y; Park MJ; Park YH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576224
[TBL] [Abstract][Full Text] [Related]
40. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
